According to BridgeBio Pharma 's latest financial reports the company's current earnings (TTM) are -C$0.52 B. In 2023 the company made an earning of -C$0.79 B a decrease over its 2022 earnings that were of -C$0.56 B.The earnings displayed on this page is the company's Pretax Income.